GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Machinery, Furniture, Equipment

Curocell (XKRX:372320) Machinery, Furniture, Equipment : ₩33,934.56 Mil (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Machinery, Furniture, Equipment?

Curocell's Machinery, Furniture, Equipment for the quarter that ended in Jun. 2023 was ₩33,934.56 Mil.

Curocell's quarterly Machinery, Furniture, Equipment increased from Jun. 2022 (₩0.00 Mil) to Dec. 2022 (₩9,356.18 Mil) and increased from Dec. 2022 (₩9,356.18 Mil) to Jun. 2023 (₩33,934.56 Mil).

Curocell's annual Machinery, Furniture, Equipment increased from Dec. 2021 (₩8,571.79 Mil) to Dec. 2022 (₩9,356.18 Mil) and increased from Dec. 2022 (₩9,356.18 Mil) to Dec. 2023 (₩38,126.23 Mil).


Curocell Machinery, Furniture, Equipment Historical Data

The historical data trend for Curocell's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Machinery, Furniture, Equipment Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Machinery, Furniture, Equipment
1,494.53 8,128.97 8,571.79 9,356.18 38,126.23

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Machinery, Furniture, Equipment - 9,356.18 33,934.56 38,126.23

Curocell Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.


Curocell (XKRX:372320) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines